Skip to main content
Clinical Trials/ISRCTN93410321
ISRCTN93410321Completed未知

Personalised nutrition in non-alcoholic fatty liver disease (NAFLD): Feasibility of a nutrigenomic therapeutic approach

ewcastle upon Tyne Hospitals NHS Foundation Trust0 sites49 target enrollmentStarted: February 10, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
49

Study Overview

Brief Summary

2021 Protocol article in http://dx.doi.org/10.1136/bmjopen-2020-045922 (added 15/08/2022)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Aged 18-80 years
  • 2. NAFLD confirmed on liver biopsy or by clinical diagnosis with imaging evidence of steatosis
  • 3. Weekly alcohol consumption <14 units (women) or <21 units (men) in last 24 months
  • 4. Weight stable (+/-5%) for 3 months
  • 5. Capacity to provide informed consent.
  • 6. Ability to write and converse in English without assistance of an interpreter

Exclusion Criteria

  • 1. Liver neoplasm/cancer within 5 years (except squamous cell carcinoma)
  • 2. Evidence of co-existent liver disease/presence of secondary causes of NAFLD (except Gilbert's syndrome).
  • 3. Decompensated NASH-cirrhosis (Child Pugh >5-6)
  • 4. Uncontrolled psychiatric disorder (e.g. acute psychosis)
  • 5. Uncontrolled medical condition (e.g. HbA1c >80mmol/l or acute coronary event or stroke within 12 months)
  • 6. Active eating disorder
  • 7. Active substance misuse
  • 8. Prescribed other dietary regimens+/-food intolerances or food allergies
  • 9. Mediterranean diet point score (MEDAS) >8 (high MD consumption)
  • 10. Previous weight loss surgery
  • 11. Taking anti-obesity medications+/-engaged in structured, multi-component weight management interventions (specialist, community or commercial providers)
  • 12. Insulin use
  • 13. Pregnancy/ lactation

Investigators

Sponsor
ewcastle upon Tyne Hospitals NHS Foundation Trust

Similar Trials